Loading institutional data...
Loading institutional data...
Held by 774 of 5,944 reporting institutions (98th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $574M dividends + $0 buybacks = $574M returned on -$2.4B FCF.
4 consecutive years of dividend increases · -2%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 3%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $38M is below the $354M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2013-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~4.3% on $21.1B of debt.
Cash of $38M is below short-term debt of $2.4B — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.36B 100.0% | $8.64B 100.0% | $8.70B 100.0% | $9.32B 100.0% | $8.35B 100.0% | $7.42B 100.0% | $7.56B 100.0% | $6.28B 100.0% | $5.70B 100.0% | $7.53B 100.0% |
| Cost of Revenue | $4.0M 0.0% | $3.0M 0.0% | $99.0M 1.1% | $204.0M 2.2% | $208.0M 2.5% | $257.0M 3.5% | $257.0M 3.4% | $40.0M 0.6% | $33.0M 0.6% | $1.98B 26.3% |
| Total Operating Expenses | $7.25B 77.5% | $6.65B 77.0% | $6.94B 79.8% | $7.75B 83.2% | $6.99B 83.7% | $6.38B 86.0% | $6.49B 85.8% | $5.41B 86.2% | $4.70B 82.4% | $6.50B 86.4% |
| Operating Income | $2.11B 22.5% | $1.99B 23.0% | $1.76B 20.2% | $1.57B 16.8% | $1.36B 16.3% | $1.04B 14.0% | $1.07B 14.2% | $868.0M 13.8% | $1.00B 17.6% | $1.02B 13.6% |
| Interest Expense | $903.0M 9.7% | $838.0M 9.7% | $701.0M 8.1% | $524.0M 5.6% | $508.0M 6.1% | $501.0M 6.8% | $528.0M 7.0% | $361.0M 5.8% | $313.0M 5.5% | $338.0M 4.5% |
| Interest & Investment Income | — | — | $9.0M 0.1% | $3.0M 0.0% | — | $3.0M 0.0% | $17.0M 0.2% | $24.0M 0.4% | $0 0.0% | — |
| Other Income (Expense), net | -$863.0M -9.2% | -$776.0M -9.0% | -$673.0M -7.7% | -$149.0M -1.6% | -$585.0M -7.0% | -$476.0M -6.4% | -$526.0M -7.0% | -$317.0M -5.1% | -$73.0M -1.3% | -$337.0M -4.5% |
| Pretax Income | $1.25B 13.3% | $1.21B 14.0% | $1.09B 12.5% | $1.42B 15.2% | $778.0M 9.3% | $563.0M 7.6% | $545.0M 7.2% | $551.0M 8.8% | $930.0M 16.3% | $686.0M 9.1% |
| Income Tax Expense | $195.0M 2.1% | $195.0M 2.3% | $170.0M 2.0% | $360.0M 3.9% | $110.0M 1.3% | $80.0M 1.1% | $30.0M 0.4% | $155.0M 2.5% | -$778.0M -13.7% | $254.0M 3.4% |
| Net Income | $1.05B 11.2% | $1.02B 11.8% | $917.0M 10.5% | $1.06B 11.3% | $1.49B 17.8% | -$773.0M -10.4% | $791.0M 10.5% | $368.0M 5.9% | $1.79B 31.4% | $432.0M 5.7% |
| Per Share | ||||||||||
| EPS (Basic) | $1.61 | $1.58 | $1.37 | $1.60 | $2.35 | $-1.79 | $1.34 | $0.74 | $4.16 | $1.00 |
| EPS (Diluted) | $1.60 | $1.58 | $1.37 | $1.59 | $2.28 | $-1.79 | $1.33 | $0.74 | $4.13 | $1.00 |
| Weighted Avg Shares (Basic) | 652.7M | 643.2M | 630.9M | 629.4M | 592.9M | 531.0M | 502.1M | 448.8M | 431.0M | 430.6M |
| Weighted Avg Shares (Diluted) | 655.6M | 644.1M | 633.2M | 632.3M | 609.9M | 531.0M | 505.2M | 452.5M | 434.3M | 433.6M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 95 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GEV | $249.3B | 52.3× | 124.5× | 6.5× | 9.0% | 19.8% | 12.8% | 43.7% | 43.4% | 0.0× | 2,989 |
| NEE | $169.3B | 24.6× | — | 6.6× | 9.8% | — | 26.5% | 12.5% | 4.6% | — | 2,911 |
| SO | $95.7B | 22.1× | — | 3.2× | 10.6% | — | 14.7% | 12.1% | 11.8% | — | 2,268 |
| DUK | $92.2B | 18.8× | 10.7× | 2.9× | 5.6% | — | 15.7% | 9.6% | 3.7% | 5.1× | 2,360 |
| CEG | $82.0B | 35.5× | 21.5× | 3.2× | 8.3% | — | 9.1% | 16.0% | 9.9% | 2.2× | 1,836 |
| AEP | $65.8B | 18.3× | 12.9× | 3.0× | 10.9% | — | 16.9% | 11.9% | 4.8% | 5.3× | 1,854 |
| D | $56.5B | 18.6× | — | 3.4× | 14.2% | — | 18.2% | 10.3% | 3.8% | — | 1,421 |
| SRE | $53.6B | 29.9× | — | 3.9× | 3.9% | — | 13.4% | 5.8% | 5.1% | — | 1,217 |
| VST | $48.5B | 65.8× | 17.1× | 2.7× | 3.0% | — | 5.3% | 18.5% | 3.9% | 4.8× | 1,246 |
| XEL | $45.9B | 21.5× | — | — | — | — | — | 8.5% | 3.5% | — | 1,208 |
| ETR | $45.7B | 26.4× | 13.1× | 3.5× | 9.0% | — | 13.7% | 10.5% | 3.9% | 5.2× | 1,224 |
| EXC | $43.6B | — | 11.1× | 1.8× | 5.3% | — | 11.4% | 9.6% | 3.6% | 5.9× | 1,230 |
| ED | $38.7B | 19.0× | — | 2.3× | 10.9% | — | 12.0% | 8.4% | 4.0% | — | 1,368 |
| PEG | $35.3B | 16.8× | — | 2.9× | 18.3% | — | 17.3% | 12.4% | 5.3% | — | 1,231 |
| WEC | $34.1B | 21.8× | 14.6× | 3.5× | 14.0% | 66.7% | 15.9% | 11.1% | 4.5% | 5.5× | 1,310 |
| AEE | $28.7B | 19.4× | — | 3.3× | 15.4% | — | 16.6% | 10.9% | 4.5% | — | 884 |
| AWK | $27.0B | 24.3× | 10.3× | 5.3× | 10.1% | — | 21.7% | 10.3% | 8.9% | 0.6× | 1,100 |
| FE | $26.4B | 26.0× | 6.9× | 1.8× | 12.0% | — | 6.8% | 8.2% | 7.9% | 0.1× | 894 |
| ATO | $26.2B | 21.7× | 11.3× | 5.6× | 12.9% | — | 25.5% | 8.8% | 8.8% | — | 961 |
| ES | $25.9B | 15.1× | 10.0× | 1.9× | 13.8% | — | 12.5% | 10.5% | 3.8% | 5.2× | 1,012 |
| PPL | $25.2B | 21.1× | 12.4× | 2.8× | 6.9% | — | 13.1% | 7.9% | 3.5% | 5.4× | 947 |
| CNP | $25.2B | 24.1× | 12.7× | 2.7× | 8.3% | 100.0% | 11.2% | 9.4% | 3.3% | 5.8× | 774 |
| EIX | $21.4B | 4.8× | 5.8× | 1.1× | 9.8% | — | 23.1% | 25.4% | 8.0% | 3.7× | 1,005 |
| CMS | $20.3B | 18.8× | 12.7× | 2.4× | 13.6% | — | 12.5% | 11.7% | 3.8% | 6.2× | 762 |
| NRG | $20.2B | 26.5× | 9.8× | 0.7× | 9.2% | — | 2.8% | 51.4% | 4.8% | 5.1× | 1,010 |
Peers = companies sharing CNP's sector (Utilities) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
Where each multiple sits in its own 14-yr range · 96th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 0.6 | 3.4 | 3.5 | 2.5 | 2.2 | 1.1 | 0.0 | 0.0 |
| Operating Income | 13.8 | 14.2 | 14.0 | 16.3 | 16.8 | 20.2 | 23.0 | 22.5 |
| Income Tax | 2.5 | 0.4 | 1.1 | 1.3 | 3.9 | 2.0 | 2.3 | 2.1 |
| Net Income | 5.9 | 10.5 | -10.4 | 17.8 | 11.3 | 10.5 | 11.8 | 11.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CNP: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.